Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001486 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetic Study of Schizophrenia

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 348 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Publications: 8 to 9
  2. New version filed on ClinicalTrials.gov
  3. 38 versions Re-verified since Mar 7, 2025, no change to tracked fieldsv309-v346
  4. Trial status: Recruiting to Completed Enrollment target: estimated 6150 to confirmed 4914v308 Show 1 more changeShow less
    • Enrollment target: estimated 6150 to confirmed 4914
  5. 9 versions Re-verified since Oct 6, 2024, no change to tracked fieldsv299-v307
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function to better understand how to treat and prevent this illness.
Trial Details
NCT Number NCT00001486
Lead Sponsor National Institute of Mental Health (NIMH)
Collaborators: National Institutes of Health Clinical Center (CC)
Conditions Schizoaffective Disorder, Schizophrenia
Enrollment 4,914 participants
Start Date
Updated on ClinicalTrials.gov